← Back to Analyst Consensus 
FHTX Buy
Foghorn Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 3 downgrades / 2 reiterations from 5 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 2, 2026 | Wedbush | downgrade | Outperform → Neutral | — | 58% |
| Oct 2, 2026 | TD Cowen | downgrade | Buy → Hold | — | 54% |
| Oct 2, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Oct 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Oct 2, 2026 | BTIG | downgrade | Buy → Neutral | — | 52% |
| Mar 12, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Mar 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 17, 2026 | Jefferies | maintain | Buy → Buy | $12 | 52% |
| Dec 18, 2025 | BTIG | initiate | — → Buy | $11 | 52% |
| Dec 4, 2025 | Stifel | initiate | — → Buy | $12 | 53% |
| Nov 7, 2025 | Guggenheim | initiate | — → Buy | $12 | 52% |
| May 15, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $9 | 53% |
| Apr 30, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $9 | 53% |
| Apr 30, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Apr 23, 2025 | JMP Securities | initiate | — → Market Outperform | $9 | 53% |
| Mar 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Jan 30, 2025 | B. Riley Securities | initiate | — → Buy | $10 | 55% |
| Dec 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Dec 16, 2024 | Jefferies | maintain | Buy → Buy | $14 | 52% |
| Sep 24, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $9 | 54% |
| Sep 3, 2024 | Jefferies | initiate | — → Buy | $18 | 52% |
| Aug 19, 2024 | Evercore ISI Group | initiate | — → Outperform | $20 | 58% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Aug 9, 2024 | Wedbush | reiterate | Outperform → Outperform | $13 | 58% |
| May 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| May 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Apr 10, 2024 | Wedbush | reiterate | Outperform → Outperform | $13 | 58% |
| Apr 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 8, 2024 | Wedbush | reiterate | Outperform → Outperform | $13 | 58% |
| Nov 13, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $6 | 54% |
| Aug 7, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jul 6, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $10 | 54% |
| Jun 29, 2023 | Goldman Sachs | maintain | Buy → Buy | $19 | 54% |
| Jun 28, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jun 8, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| May 9, 2023 | Wedbush | maintain | — → Outperform | $14 | 58% |
| May 9, 2023 | HC Wainwright & Co. | maintain | — → Buy | $20 | 44% |
| Apr 25, 2023 | BMO Capital | maintain | — → Outperform | $19 | 53% |
| Apr 25, 2023 | Wedbush | maintain | — → Outperform | $15 | 58% |
| Mar 28, 2023 | B of A Securities | initiate | — → Buy | $10 | 53% |
| Mar 10, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $25 | 44% |
| Mar 10, 2023 | Wedbush | maintain | — → Outperform | $20 | 58% |
| Jan 5, 2023 | BMO Capital | initiate | — → Outperform | $20 | 53% |
| Nov 21, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $14 | 54% |
| Aug 24, 2022 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $15 | 54% |
| Aug 10, 2022 | HC Wainwright & Co. | maintain | — → Buy | $25 | 44% |
| May 24, 2022 | Goldman Sachs | maintain | — → Buy | $21 | 54% |
| May 23, 2022 | Morgan Stanley | maintain | — → Overweight | $25 | 54% |
| May 20, 2022 | HC Wainwright & Co. | maintain | — → Buy | $18 | 44% |
| Dec 15, 2021 | Morgan Stanley | maintain | — → Overweight | $26 | 54% |
Price Target Trend
Apr 24, 2026 Latest: $4.17 Oct 25, 2026
EPS Estimates
0y $-0.93
Lo: $-1.22 Hi: $-0.70
8 analysts 0q $-0.25
Lo: $-0.41 Hi: $-0.15
7 analysts +1y $-1.03
Lo: $-2.01 Hi: $-0.67
8 analysts ▲4
+1q $-0.25
Lo: $-0.33 Hi: $-0.16
7 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days